Defence Therapeutics Inc.

PRESS RELEASE

published on 06/17/2024 at 08:00, 2 years 2 months ago

DEFENCE’S CHIEF SCIENTIFIC OFFICER DR. MOUTIH RAFEI DISCUSSES THE ACCUM PLATFORM FOR CANCER TREATMENTS ON MONEY TALK RADIO WITH ELLIS MARTIN
Defence Therapeutics Inc.'s Chief Scientific Officer Dr. Moutih Rafei discusses the ACCUM platform for cancer treatments on Money Talk Radio with Ellis Martin

Defence Therapeutics Inc. Cancer Treatments ACCUM Platform Dr. Moutih Rafei Money Talk Radio
BRIEF

published on 06/10/2024 at 08:05, 2 years 2 months ago

Defence Therapeutics participera au congrès annuel 2024 du SNMMI à Toronto

Thérapeutique De Défense SNMMI AccuTRIC™ Médecine Nucléaire Imagerie Moléculaire
BRIEF

published on 06/10/2024 at 08:05, 2 years 2 months ago

Defence Therapeutics to Attend 2024 SNMMI Annual Meeting in Toronto

Defence Therapeutics Nuclear Medicine SNMMI AccuTRIC™ Molecular Imaging
PRESS RELEASE

published on 06/10/2024 at 08:00, 2 years 2 months ago

DEFENCE TO PARTICIPATE TO 2024 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ANNUAL MEETING IN TORONTO ON JUNE 11, 2024
Defence Therapeutics Inc. to participate in the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024, presenting their novel Radio-Immuno-Conjugate (RIC) for cancer treatment

Cancer Treatment Defence Therapeutics Inc. Molecular Imaging Society Of Nuclear Medicine Radio-Immuno-Conjugate
BRIEF

published on 06/06/2024 at 08:05, 2 years 2 months ago

L'étude AccuTOX de Defense Therapeutics publiée dans le Journal of Translational Medicine

Immunothérapie Essais Cliniques Thérapeutique De Défense AccuTOX Anti-cancer
BRIEF

published on 06/06/2024 at 08:05, 2 years 2 months ago

Defence Therapeutics' AccuTOX Study Published in Journal of Translational Medicine

Clinical Trials Immunotherapy Defence Therapeutics AccuTOX Anti-cancer
PRESS RELEASE

published on 06/06/2024 at 08:00, 2 years 2 months ago

DEFENCE’S ACCUTOX PUBLISHED IN THE PRESTIGIOUS JOURNAL OF TRANSLATIONAL MEDICINE ITS PEER STUDY WITH PRECLINICAL DATA ON ACCUTOX AS AN ANTI-CANCER MOLECULE
Defence Therapeutics Inc.'s AccuTOX published in the prestigious Journal of Translational Medicine along with preclinical data on AccuTOX as an anti-cancer molecule. Study highlights AccuTOX's superior therapeutic properties and versatility for different cancer treatments

Preclinical Data Defence Therapeutics Inc. AccuTOX Journal Of Translational Medicine Anti-cancer Molecule
BRIEF

published on 05/14/2024 at 08:05, 2 years 3 months ago

Defence Therapeutics étend son portefeuille de brevets à l'échelle mondiale

Thérapeutique De Défense Délivrance De Brevet Innovation Dans Les Soins De Santé Vaccin Immuno-oncologique Système De Délivrance De Médicaments
BRIEF

published on 05/14/2024 at 08:05, 2 years 3 months ago

Defence Therapeutics Expands Patent Portfolio Globally

Defence Therapeutics Patent Issuance Drug Delivery System Innovation In Healthcare Immune-Oncology Vaccine
PRESS RELEASE

published on 05/14/2024 at 08:00, 2 years 3 months ago

DEFENCE THERAPEUTICS STRENGTHENS AND EXPANDS GLOBAL PATENT PROTECTION ON KEY TECHNOLOGIES
Defence Therapeutics strengthens and expands global patent protection on key technologies, including vaccine enhancer platform and ADC platform technology. The new patents and allowances showcase the company's commitment to innovation in biopharmaceuticals

Biopharmaceuticals Defence Therapeutics Patent Protection Vaccine Enhancer ADC Platform Technology

Published on 08/31/2026 at 17:22, 3 hours 21 minutes ago

ACCESS Newswire Expands the Marketplace with Two New Partners: TVEyes and Listicle Liaison
Published on 08/31/2026 at 15:50, 4 hours 53 minutes ago

Sarama Resources - Grant of Equity Incentives
Published on 08/31/2026 at 15:00, 5 hours 43 minutes ago

Super Copper Featured at OTC Markets' Virtual Investor Conference, Presentation Replay Now Available
Published on 08/31/2026 at 14:30, 6 hours 13 minutes ago

Boron One Holdings Inc. Project Update
Published on 08/31/2026 at 14:30, 6 hours 13 minutes ago

While Measles Cases Continue to Increase in The USA and Globally, NanoViricides is Getting Ready for Clinical Trials of Its Revolutionary Broad-spectrum Drug Candidate NV-387 as A Treatment for Measles

View all ACCESSWIRE

Published on 08/31/2026 at 19:31, 1 hour 12 minutes ago

DEAG reports strong results for the first half of 2026
Published on 08/31/2026 at 19:15, 1 hour 27 minutes ago

CGTN: How China-Kyrgyzstan 'golden' ties deliver for both nations and the region
Published on 08/31/2026 at 19:00, 1 hour 43 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 24 AOUT 2026 au 28 AOUT 2026
Published on 08/31/2026 at 18:20, 2 hours 23 minutes ago

CPI PROPERTY GROUP publishes financial results for the first half of 2026
Published on 08/31/2026 at 18:06, 2 hours 36 minutes ago

MELLENU HOLDING S.A. REPORTS RESULTS FOR THE SIX MONTHS ENDING 30 JUNE 2026

View all EQS

Published on 08/31/2026 at 18:00, 2 hours 43 minutes ago

MISE A DISPOSITION RAPPORT FINANCIER ANNUEL 2025/2026
Published on 08/31/2026 at 17:45, 2 hours 58 minutes ago

Disclosure of transactions in own shares from August 24 to August 28, 2026
Published on 08/31/2026 at 17:45, 2 hours 58 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 24 au 28 août 2026
Published on 08/31/2026 at 17:45, 2 hours 58 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 08/31/2026 at 17:45, 2 hours 58 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE

News